Literature DB >> 29765827

A Cross-sectional Survey of the North American Skull Base Society: Current Practice Patterns of Vestibular Schwannoma Evaluation and Management in North America.

Matthew L Carlson1,2, Jamie J Van Gompel1,2, R Mark Wiet3, Nicole M Tombers1, Anand K Devaiah4, Devyani Lal5, Jacques J Morcos6, Michael J Link1,2.   

Abstract

Background  Very few studies have examined vestibular schwannoma (VS) management trends across centers and between providers. The objective of this study is to examine current practice trends, variance in treatment philosophies, and nuanced or controversial aspects of VS care across North America. Methods  This is a cross-sectional survey of North American Skull Base Society (NASBS) members who report regular involvement in VS care. Results  A total of 57 completed surveys were returned. Most respondents claimed to have over 20 years of experience and the majority reported working in an academic practice with an affiliated otolaryngology and/or neurosurgery residency program. Sixty-three percent of respondents claimed to evaluate VS patients in clinic with both an otolaryngologist and neurosurgeon involved. Eighty-six percent of respondents claimed to operate on VS with both an otolaryngologist and neurosurgeon involved, while only 18% of neurosurgeons and 9% of otolaryngologists performed surgery alone. There was a wide range in the number of cases evaluated at each center annually. Similarly, there was wide variation in the number of patients treated with microsurgery and radiation at each center. Additional details regarding management preferences for microsurgery, stereotactic radiosurgery, stereotactic radiotherapy, and conservative observation are presented. Conclusion  VS management practices vary between providers and centers. Overall, most centers employ a multidisciplinary approach to management with collaboration between otolaryngology and neurosurgery. Overall, survey responses concur with previous studies suggesting a shift toward conservatism in management.

Entities:  

Keywords:  acoustic neuroma; cranial fossa; microsurgery; radiosurgery; skull base surgery; vestibular schwannoma

Year:  2017        PMID: 29765827      PMCID: PMC5951692          DOI: 10.1055/s-0037-1607319

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  31 in total

1.  Surgical exposure of the internal auditory canal and its contents through the middle, cranial fossa.

Authors:  W F HOUSE
Journal:  Laryngoscope       Date:  1961-11       Impact factor: 3.325

2.  The history of stereotactic radiosurgery and radiotherapy.

Authors:  John M Lasak; John P Gorecki
Journal:  Otolaryngol Clin North Am       Date:  2009-08       Impact factor: 3.346

3.  Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management.

Authors:  Ranjith Babu; Richa Sharma; Jacob H Bagley; Jeffrey Hatef; Allan H Friedman; Cory Adamson
Journal:  J Neurosurg       Date:  2013-02-22       Impact factor: 5.115

4.  The bloody angle: 100 years of acoustic neuroma surgery.

Authors:  R T Ramsden
Journal:  J R Soc Med       Date:  1995-08       Impact factor: 5.344

5.  Current practices in vestibular schwannoma management: a survey of American and Canadian neurosurgeons.

Authors:  Matthew R Fusco; Winfield S Fisher; Benjamin M McGrew; Beverly C Walters
Journal:  Clin Neurol Neurosurg       Date:  2014-10-12       Impact factor: 1.876

6.  The Changing Landscape of Vestibular Schwannoma Management in the United States--A Shift Toward Conservatism.

Authors:  Matthew L Carlson; Elizabeth B Habermann; Amy E Wagie; Colin L Driscoll; Jamie J Van Gompel; Jeffrey T Jacob; Michael J Link
Journal:  Otolaryngol Head Neck Surg       Date:  2015-06-30       Impact factor: 3.497

Review 7.  Management of sporadic vestibular schwannoma.

Authors:  Matthew L Carlson; Michael J Link; George B Wanna; Colin L W Driscoll
Journal:  Otolaryngol Clin North Am       Date:  2015-04-15       Impact factor: 3.346

8.  Vestibular schwannoma management: current practice amongst UK otolaryngologists--time for a national prospective audit.

Authors:  Shakeel R Saeed; Ranga Suryanarayanan; Attila Dezso; Richard T Ramsden
Journal:  Ann R Coll Surg Engl       Date:  2006-09       Impact factor: 1.891

9.  Current epidemiology and management trends in acoustic neuroma.

Authors:  Thomas J Gal; Jennifer Shinn; Bin Huang
Journal:  Otolaryngol Head Neck Surg       Date:  2010-05       Impact factor: 3.497

10.  The natural history of untreated acoustic neuromas.

Authors:  B Strasnick; M E Glasscock; D Haynes; S O McMenomey; L B Minor
Journal:  Laryngoscope       Date:  1994-09       Impact factor: 3.325

View more
  4 in total

1.  Can an Imaging Marker of Consistency Predict Intraoperative Experience and Clinical Outcomes for Vestibular Schwannomas? A Retrospective Review.

Authors:  Robert J Macielak; Michael S Harris; Jameson K Mattingly; Varun S Shah; Luciano M Prevedello; Oliver F Adunka
Journal:  J Neurol Surg B Skull Base       Date:  2019-09-24

2.  Long-term natural history and patterns of sporadic vestibular schwannoma growth: A multi-institutional volumetric analysis of 952 patients.

Authors:  John P Marinelli; Zane Schnurman; Daniel E Killeen; Ashley M Nassiri; Jacob B Hunter; Katherine A Lees; Christine M Lohse; J Thomas Roland; John G Golfinos; Douglas Kondziolka; Michael J Link; Matthew L Carlson
Journal:  Neuro Oncol       Date:  2022-08-01       Impact factor: 13.029

3.  Defining current practice patterns of vestibular schwannoma management in Italy: results of a nationwide survey.

Authors:  Diego Cazzador; Elisabetta Zanoletti; Nicola Quaranta; Marco Pontrelli; Sabino Ciprelli; Francesco Signorelli; Luca Denaro; Domenico d'Avella; Giovanni Danesi
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-04       Impact factor: 2.124

Review 4.  The biological underpinnings of radiation therapy for vestibular schwannomas: Review of the literature.

Authors:  Mark C Dougherty; Seiji B Shibata; Marlan R Hansen
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.